Selection of direct-acting antiviral agents for chronic hepatitis C infection
10.3760/cma.j.issn.1007-3418.2018.03.002
- VernacularTitle:直接抗病毒药物治疗慢性丙型肝炎的方案选择
- Author:
Yajing HE
1
;
Zhihong LIU
;
Jinlin HOU
Author Information
1. 南方医科大学南方医院肝病中心暨感染内科
- Keywords:
Hepatitis C,chronic;
Therapy;
Antiviral therapy;
Clinical trial;
Direct-acting antiviral
- From:
Chinese Journal of Hepatology
2018;26(3):169-172
- CountryChina
- Language:Chinese
-
Abstract:
The elimination of hepatitis C virus(HCV) infection is still a long way to go.Directacting antiviral agents (DAAs) can make HCV completely cured by targeting various stages of its replication life cycle and meanwhile standardize and simplify the treatment.However,those relative factors may affect efficacy and safety should be considered by specialties in choosing the suitable regimens.Therefore,this article reviews various aspects of DAAs including development history,factors correlated with efficacy and safety,therapeutic regimens domestic listed and approved.
